SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-038037
Filing Date
2024-03-28
Accepted
2024-03-28 16:08:37
Documents
16
Period of Report
2024-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20240325.htm   iXBRL 8-K 53500
2 EX-1.1 nktx-ex1_1.htm EX-1.1 340871
3 EX-4.1 nktx-ex4_1.htm EX-4.1 116448
4 EX-5.1 nktx-ex5_1.htm EX-5.1 19960
5 GRAPHIC img264793915_0.jpg GRAPHIC 18129
6 GRAPHIC img264793915_1.jpg GRAPHIC 18129
  Complete submission text file 0000950170-24-038037.txt   792035

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20240325.xsd EX-101.SCH 31912
19 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20240325_htm.xml XML 4705
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 24798920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)